ArticleAntibiotics (Basel, Switzerland)2022

Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark?

Yuan-Pin Hung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.